RecruitingNot Applicable

Multicomponent Intervention Study- Blood Donors With High Cholesterol

United States100 participantsStarted 2023-02-27

Plain-language summary

The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria * Age 18 to 75 years Exclusion Criteria: * Currently taking medication to lower cholesterol * Taking any medication that can interact with statins * Pregnancy * Identified secondary cause of elevated lipids * Chronic liver disease or significantly elevated liver function tests (\> 3 times upper limit)

What they're measuring

Difference in change in LDL cholesterol levels from baseline to 6 months

Timeframe: Baseline, 6 months

Trial details

NCT IDNCT05693701

SponsorUniversity of Texas Southwestern Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-04-30

Contact for this trial

Amit Khera, MD

214.645.7500 Amit.Khera@UTSouthwestern.edu

View on ClinicalTrials.gov More Lipid Metabolism Disorder trials